OTC: EKTAF - Elekta AB (publ)

Rentabilität für sechs Monate: -12.04%
Sektor: Healthcare

Aktionsplan Elekta AB (publ)


Über das Unternehmen

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Weitere Details
It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Цена ао 6.25
Выручка 13.56
EBITDA 2.7
Число акций ао 0.38237 млрд
P/E 36.03
P/S 3.18
P/BV 5.55
EV/EBITDA 16.17
Дивиденд ао 1.2
Сайт https://elekta.com
Див.доход ао 0.0277
Валюта usd
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета sek
Preisänderung pro Tag: 0% (6.65)
Preisänderung pro Woche: +6.4% (6.25)
Preisänderung pro Monat: +6.4% (6.25)
Preisänderung über 3 Monate: +8.48% (6.13)
Preisänderung über sechs Monate: -12.04% (7.56)
Preisänderung pro Jahr: -6.6% (7.12)
Preisänderung über 3 Jahre: -4.04% (6.93)
Preisänderung über 5 Jahre: -14.96% (7.82)
Preisänderung seit Jahresbeginn: -20.36% (8.35)

Unterschätzung

Name Bedeutung Grad
P/S 1.74 8
P/BV 2.93 6
P/E 24.24 6
EV/EBITDA 10.3 7
Gesamt: 6.13

Effizienz

Name Bedeutung Grad
ROA, % 4.02 1
ROE, % 12.08 4
Gesamt: 4

Dividenden

Name Bedeutung Grad
Div yield, % 0.0291 0.08
DSI 0.8571 8.57
Gesamt: 3.5

Pflicht

Name Bedeutung Grad
Debt/EBITDA 1.76 7
Gesamt: 5.2

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 24.09 4
Rentabilität Ebitda, % 8.77 2
Rentabilität EPS, % 19.99 3
Gesamt: 4.6



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Laurent Leksell Founder & Chairman 1.64M 1952 (72 Jahr)
Mr. Gustaf Salford President & CEO 14.62M 1977 (47 Jahre)
Mr. Tobias Hagglov Chief Financial Officer N/A 1978 (46 Jahre)
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel N/A 1966 (58 Jahre)
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs N/A
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer N/A 1985 (39 Jahre)
Mr. John Lapré President of Brachy & Neuro Solutions N/A 1964 (60 Jahre)
Mr. Maurits Wolleswinkel President of Linac & Software Solutions N/A 1971 (53 Jahr)
Mr. Habib Nehme Chief Commercial Officer N/A 1964 (60 Jahre)
Mr. Peter Nyquist Head of Investor Relations N/A 1965 (59 Jahre)

Adresse: Sweden, Stockholm, Hagaplan 4 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://elekta.com